Archive | February, 2009

Photosynthetic response of Cannabis sativa L. to variations in photosynthetic photon flux densities, temperature and CO2 conditions

Physiol Mol Biol Plants. 2008 Oct; 14(4): 299–306.  Published online 2009 Feb 26. doi:  10.1007/s12298-008-0027-x PMCID: PMC3550641 Photosynthetic response of Cannabis sativa L. to variations in photosynthetic photon flux densities, temperature and CO2 conditions Suman Chandra, Hemant Lata, Ikhlas A. Khan, and  Mahmoud A. Elsohly Author information ► Copyright and License information ► This article has been cited by other articles in PMC. Abstract Effect of different photosynthetic photon flux […]

Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats.

2009 Feb;9(2):216-22. doi: 10.1016/j.intimp.2008.11.010. Epub 2008 Dec 12. Napimoga MH1, Benatti BB, Lima FO, Alves PM, Campos AC, Pena-Dos-Santos DR, Severino FP, Cunha FQ, Guimarães FS. Author information Abstract Cannabidiol (CBD) is a cannabinoid component from Cannabis sativa that does not induce psychotomimetic effects and possess anti-inflammatory properties. In the present study we tested the effects of CBD in a periodontitis experimental model […]

Emerging strategies for exploiting cannabinoid receptor agonists as medicines.

Br J Pharmacol. 2009 February; 156(3): 397–411. doi:  10.1111/j.1476-5381.2008.00048.x PMCID: PMC2697681 Emerging strategies for exploiting cannabinoid receptor agonists as medicines Roger G Pertwee Author information ► Article notes ► Copyright and License information ► This article has been cited by other articles in PMC. Go to: Abstract Medicines that activate cannabinoid CB1 and CB2 receptor are already in the clinic. These are Cesamet® (nabilone), Marinol® (dronabinol; Δ9-tetrahydrocannabinol) and […]